September 29, 2021
BARDA and NCATS announce three new EZ-BAA partners for the ImmuneChip+ program to advance tissue-chip technology for immunity, vaccine, and drug development studies
BARDA's Division of Research, Innovation, and Ventures (DRIVe) and the National Center for Advancing Translational Sciences…